Impact of COVID-19 Pandemic on Single-stage Laparoscopic Cholecystectomy and Laparoscopic Common Bile Duct Exploration Service
- Conditions
- Gallstone
- Registration Number
- NCT06974045
- Lead Sponsor
- Imperial College London
- Brief Summary
Choledocholithiasis is reported to be present in 15-20% of patients with symptomatic gallstones. The single-stage management consists of performing either laparoscopic common bile duct exploration (LCBDE) or intraoperative endoscopic retrograde cholangiopancreatography (ERCP) at the same time as laparoscopic cholecystectomy (LC).
Since the Coronavirus (COVID-19) pandemic, surgical practice has significantly been impacted. The pandemic has had ramifications on patient and staff safety, surgical techniques, minimally invasive procedures, theatre workflow, education and training.
We analysed a series of LCBDE procedures in our institution pre-, intra- and post-COVID-19 pandemic to assess the feasibility, efficacy and safety of this single-stage treatment approach following the pandemic.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 237
- Patients that underwent single-stage LC + LCBDE for the management of choledocholithiasis with concomitant gallstones.
- Patients that underwent LC only or LCBDE only
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraoperative measures 90 days Size of choledochoscope, holmium laser lithotripsy use and stone clearance rates
Postoperative complications 90 days Complications such as bile leak and pancreatitis, including hospital length of stay
- Secondary Outcome Measures
Name Time Method